Healx

Description

Healx builds AI-driven drug discovery and development tools and therapies for rare disease patients, applying AI across discovery, development and repurposing for patient-focused pharmaceutical outcomes.

Healx is located in the Cambridge ecosystem.

Related

• PurposefulPurposeful repurposes marketed drugs to find treatments and develop pharmaceutical products for rare diseases, with an AI repurposing…
• EvotecEvotec provides integrated drug discovery and preclinical development services, delivering CRO/CDMO research platforms, ADME‑Tox, biologics…
• Qubit PharmaceuticalsQubit Pharmaceuticals develops quantum- and AI-driven molecular modeling platforms and drug discovery tools used to design novel drug…
• NucleraNuclera builds and supplies eProtein Discovery systems, cartridges, reagents and services for multiplex cell-free protein screening used by…
• IktosIktos builds generative AI and robotics systems for drug discovery, producing platforms for de novo molecule design, retrosynthesis…
• bit.biobit.bio provides deterministically programmed human iPSC-derived cells and CRISPR screening services for research and drug discovery,…
• Jazz PharmaceuticalsJazz Pharmaceuticals develops and commercializes medicines for people with rare diseases, focusing on therapies for epilepsies, cancers and…
• KvantifyKvantify develops software and services that route calculations across quantum and classical architectures, accelerating molecular…
• Isomorphic LabsIsomorphic Labs uses machine learning to transform drug discovery by building predictive and generative AI models for designing molecules…